Legacy Capital Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pacira BioSciences
PCRX
|
+$1.26M |
| 2 |
AbbVie
ABBV
|
+$804K |
| 3 |
Walt Disney
DIS
|
+$713K |
| 4 |
VeriSign
VRSN
|
+$554K |
| 5 |
Marriott International
MAR
|
+$512K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$952K |
| 2 |
iShares MSCI Singapore ETF
EWS
|
+$929K |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
+$775K |
| 4 |
Baidu
BIDU
|
+$703K |
| 5 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$477K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 18.83% |
| 2 | Healthcare | 18.08% |
| 3 | Technology | 16.35% |
| 4 | Industrials | 11.08% |
| 5 | Financials | 9.81% |
Similar funds
Legacy Capital Partners's Q3 2015 Portfolio in Review
As of Q3 2015, Legacy Capital Partners held 124 positions worth $147M, down 4% from $154M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Legacy Capital Partners deployed $5.43M of net new capital in Q3 2015, opening 11 new positions and adding to 49 existing holdings. Its largest new stake was Pacira BioSciences: 20,650 shares worth $849K.
By sector, the portfolio is most concentrated in Consumer Staples at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Potash Corp Of Saskatchewan, an estimated $775K trimmed.
- Legacy Capital Partners's largest Q3 2015 buy was Pacira BioSciences: 20,650 shares worth $849K.
- Legacy Capital Partners added most to AbbVie in Q3 2015, an estimated $804K increase.
- Legacy Capital Partners's biggest Q3 2015 reduction was Potash Corp Of Saskatchewan, cutting an estimated $775K.
- Legacy Capital Partners fully exited Oracle in Q3 2015, selling an estimated $952K.
- Legacy Capital Partners's ten largest holdings make up 28% of its $147M portfolio in Q3 2015.
- Legacy Capital Partners opened 11 new positions and closed 14 in Q3 2015.
- Legacy Capital Partners's portfolio value fell 4% quarter-over-quarter to $147M.
Based on Legacy Capital Partners's 13F filing for Q3 2015, filed 9 Nov 2015.